Multiple ligation-Assisted recombinase polymerase amplification for highly sensitive and selective colorimetric detection of SARS-CoV-2Article Published on 2023-01-152022-11-15 Journal: Talanta [Category] SARS, 치료기술, 치료제, [키워드] acute respiratory syndrome amplification Analysis Bacterial colorimetric detection Colorimetric sensing conditions coronavirus detection system diagnosing disease Diseases effective Genome isothermal isothermal amplification limit of detection Multiple PK-probe point-of-care polymerase probe Pyrophosphate recombinase polymerase amplification Recombinase polymerase amplification (RPA) RNA robust SARS-CoV-2 SARS-CoV-2. selective sensitivity [DOI] 10.1016/j.talanta.2022.123835 PMC 바로가기
A systematic review of the advancement on colorimetric nanobiosensors for SARS-CoV-2 detectionArticle Published on 2023-01-052022-11-15 Journal: Journal of pharmaceutical and biomedical analysis [Category] SARS, 진단, 치료기술, [키워드] addition analyzed applied approach articles biosensors chain Clinical diagnosis coronavirus COVID-19 database Detection limit Diagnosis devices diagnostic diagnostics Direct ELISA enzyme-linked immunosorbent assay faster highlight individual lateral flow immunoassay Masks Nanosensors original form pandemic PCR POC POC. point-of-care reaction researcher SARS-CoV-2 SARS-CoV-2 detection SARS-CoV-2 viruses Science searched selective severe respiratory syndrome specificity surgical swabs systematic review virus detection Web of Science [DOI] 10.1016/j.jpba.2022.115087 PMC 바로가기
SARS-CoV-2 shedding dynamics and transmission in immunosuppressed patients면역 억제 환자의 SARS-CoV-2 발산 역학 및 전파Article Published on 2022-12-012022-09-11 Journal: Virulence [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus adjust analysed anatomic site characterized collected conducted coronavirus Diagnosis Diversity dominant E484K first positive fitness genetic change Genome genomic Host hosts household transmission Immunosuppressed immunosuppressed patient immunosuppressed patients in urine in vivo Infection Interaction knowledge long-term viral shedding mother mutate Mutation mutation dynamics N501Y occurred P681R Patient replicate residue residues SARS-CoV-2 SARS-CoV-2 evolution selective Sequencing severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 specific treatment Spike protein spread to Substitution temporal dynamics Transmission two patients Urine variant variant of concern variants variants of concern virus whole genome Whole genome sequencing whole genome sequencing. whole-genome sequencing [DOI] 10.1080/21505594.2022.2101198 PMC 바로가기 [Article Type] Article
RASCL: Rapid Assessment of Selection in CLades through molecular sequence analysisArticle Published on 2022-11-022022-11-16 Journal: PLoS ONE [Category] SARS, 변종, 치료기술, [키워드] acting Analysis assessment automatically COVID-19 pandemic dataset datasets detect evaluate Evolution Genome Genome sequences genomes genomic include Intensive Lineage lineages molecular Mutation natural selection Notation object pathogen Phylogenetic Rapid SARS-CoV-2 selected Selection selective sensitivity sequence Sequence analysis sequencing error Surveillance underlie unmet need variants of concern whole genes yielding [DOI] 10.1371/journal.pone.0275623 PMC 바로가기
Accurate identification of SARS-CoV-2 variant delta using graphene/CRISPR-dCas9 electrochemical biosensorArticle Published on 2022-11-012022-11-15 Journal: Talanta [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] Accurate identification amplified B.1.617.2 Beta clinical samples clinical sensitivity clinical specificity CRISPR-dCas9 Delta Detection limit develop electrochemical biosensor Gamma identify other variants probe provide reproducibility SARS-CoV-2 SARS-CoV-2 variant selective the SARS-CoV-2 variant Variant delta. variant of SARS-CoV-2 [DOI] 10.1016/j.talanta.2022.123687 PMC 바로가기
Novel approach based on GQD-PHB as anchoring platform for the development of SARS-CoV-2 electrochemical immunosensorArticle Published on 2022-11-012022-11-15 Journal: Analytica chimica acta [Category] COVID19(2023년), SARS, 진단, 치료기술, 치료제, [키워드] addition analyzed antibodies antibody approach Blood carbon Carbon nanomaterial Concentration conditions coronavirus spike protein decrease develop domain Dot DPV Electrochemical devices Fever functional Graphene human serum Immunosensors construction. Interaction investigated matrix effect Modification novel PBS performed platform probe Protein provided pulse quantum RBD SARS-CoV-2 selective SEM serum shown was tested was used [DOI] 10.1016/j.aca.2022.340442 PMC 바로가기
Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced ImmunityArticle Published on 2022-10-262022-11-15 Journal: mBio [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] accelerate antibody antibody function Antibody Response Antibody titer Antigen binding antibody Combination comparable conserved COVID-19 cross-reactivity disease dose expected Fc-receptors first dose function functional functions humoral immune response hybrid Hybrid immunity immune immune priming Immunity immunization immunodominance increases in indicate individual individuals Infection magnitude modify mRNA mRNA vaccination mRNA vaccine mRNA vaccines neutralizing antibody offer Quality receive recent Region remained resulting robust SARS-CoV-2 second dose selective serology shift spike subsequent symptomatic T cell the SARS-CoV-2 the Spike unique vaccination Vaccine vaccine-induced immune response vaccinee Vaccines Vaccines. variants of concern virus while [DOI] 10.1128/mbio.01647-22 PMC 바로가기
Dual Monoclonal Antibodies on Sars-Cov-2 Alpha and Delta Variants: Clinical and Virological EfficacyArticle Published on 2022-10-262022-11-15 Journal: Microbiology Spectrum [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, 진단, 치료제, [키워드] analysis antibodies antibody antiviral efficacy association bamlanivimab/etesevimab casirivimab/imdevimab clinical conducted Course COVID-19 Delta Dual therapy Efficacy France genomic glycoprotein growth high risk highlight joint management monoclonal monoclonal antibodies monoclonal antibody Mutation mutation selection. neutralization omicron overlap Paris Patient patients died patients treated Prevent Protein resistance mechanism SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 variant SARS-CoV-2-positive patients selected selective severe COVID-19 spike Spread the Spike therapy treat Treatment treatment initiation variant variants viral genome Viral load viral mutation was done [DOI] 10.1128/spectrum.02152-22 PMC 바로가기
SARS-CoV-2 wastewater monitoring using a novel PCR-based method rapidly captured the Delta-to-Omicron ΒΑ.1 transition patterns in the absence of conventional surveillance evidenceArticle Published on 2022-10-202022-11-15 Journal: The Science of the total environment [Category] COVID19(2023년), SARS, 변종, 치료기술, 치료제, [키워드] absence acquisition amplify Analysis applicability approach characterized clinical sample Conventional Delta delta variant Delta wave dependent on described doubling early warning epidemic wave epidemiological situation Epidemiology Evidence genomic genomic region genotyping Greece influence information Measures methodology omicron Omicron BA.1 PCR amplification PCR-based method plant Prevalence proportion provide Public health interventions quantification rapid increase reached real-time RT-PCR reported SARS-CoV-2 SARS-CoV-2 surveillance selective Sequencing state Surveillance surveillance data Thessaloniki variant Viral load virus wastewater Wastewater-based epidemiology. [DOI] 10.1016/j.scitotenv.2022.156932 PMC 바로가기
Safety, Tolerability, and Pharmacokinetics of the Novel Antiviral Agent Ensitrelvir Fumaric Acid, a SARS-CoV-2 3CL Protease Inhibitor, in Healthy AdultsArticle Published on 2022-10-182022-11-15 Journal: Antimicrobial Agents and Chemotherapy [Category] COVID19(2023년), SARS, 치료제, [키워드] 3CL acid administration adverse event affected agent Antiviral assessment AUC C max COVID-19 demonstrated dose doses drug-drug interaction Effect ensitrelvir first-in-human Food Intake geometric increase in Infection inhibitor Japanese mild in severity MOST novel oral dosing P450 participant Participants participants with SARS-CoV-2 pharmacokinetics phase 1 study Placebo plasma proportionality protease Protease inhibitor protease inhibitor. Randomized reduced resolved Safety SARS-CoV-2 selective single dose substrate T max Tolerability Treatment viral replication [DOI] 10.1128/aac.00632-22 PMC 바로가기